Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1819-1827

  Isshi, Kunio ^a   Hirohata, Shunsei ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; RIBOSOME PROTEIN;

ARTICLE; CELL STRAIN HL 60; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATIENT CODING; PRIORITY JOURNAL; PROTEIN PURIFICATION; PSYCHOSIS; SYSTEMIC CIRCULATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUPUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE PROTEINS; NEURONS; PROTOZOAN PROTEINS; PSYCHOTIC DISORDERS; RIBOSOMAL PROTEINS;

EID: 0031709624     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y     Document Type: Article

References (25)

1. Gibson T, Myers AR. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis 1976;35:398-406.
2. Harris EN, Hughes GRV. Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol 1985;8:251-66.
3. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987;317:265-71.
4. Schneebaum AB, Singleton JD, West SG, Blodgett JK, Allen LG, Cheronis JC, et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991;90:54-62.
5. Isshi K, Hirohata S. Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1996;39:1483-90.
6. Golombek SJ, Graus F, Elkon KB. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum 1986;29:1090-7.
7. Bluestein HG, Zvaifler NJ. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976;57:509-16.
8. Bresnihan B, Oliver M, Williams B, Hughes GRV. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum 1979;22:313-20.
9. Wilson HA, Winfield JB, Lahita RG, Koffler D. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum 1979;22:458-62.
10. Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA. Serum lymphocytoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis 1990;49:249-53.
11. Bluestein HG, Williams GW, Steinberg AD. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatrie manifestations of systemic lupus erythematosus. Am J Med 1981; 70:240-6.
12. Kelly MC, Denburg JA. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatrie systemic lupus erythematosus and related conditions. J Rheumatol 1987;14:740-4.
13. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
14. Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA III, Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 1983;74:837-44.
15. Hirohata S, Hirose S, Miyamoto T. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus: their use as estimates of central nervous system disease activity. Arch Intern Med 1985;145:1843-6.
16. Hirohata S, Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 1990;33:644-9.
17. Hanson VG, Horowitz M, Rosenbluth D, Spiera H, Puszkin S. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med 1992;176:565-73.
18. Yoshio T, Masuyama J-I, Kano S. Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells. J Rheumatol 1996;23:1311-2.
19. Koren E, Reichlin MW, Koscec M, Fugate RD, Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 1992;89: 1236-41.
20. How A, Dent PB, Liao S-K, Denburg LA. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1985;28:789-95.
21. Hirohata S, Kosaka M. Association of anti-Sm antibodies with organic brain syndrome secondary to systemic lupus erythematosus [letter]. Lancet 1994;343:796.
22. Simon J, Simon O. Effect of passive transfer of anti-brain antibodies to a normal recipient. Exp Neurol 1975;47:523-34.
23. Karpiak SE, Graf L, Rappaport MM. Antiserum to brain gangliosides produces recurrent epileptiform activity. Science 1976;194: 735-7.
24. Kobiler D, Fuchs S, Samuel D. The effect of antisynaptosomal plasma membrane antibodies on memory. Brain Res 1976;115: 129-38.
25. Shiozawa S, Kuroki Y, Kim M, Hirohata S, Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum 1992;35:417-22.